Financial statements Apipharma
Cash flow statement of Apipharma
Company age:
Age:
3 y. 5 m. 6 d.
Share capital:
Share capital:
10 050 PLN
Cash inflows of APIPHARMA
|
Year
|
2022
|
2023
|
|---|---|---|
| Net cash from operating expenses | -79 596,34 | - |
| Net cash flow from investing activities | -6 910,57 | - |
| Net cash flow from financial activities | -192 701,30 | - |
| Total net cash flow | -279 208,21 | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.